Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) of the Skin
This study is currently recruiting participants.
Verified May 2013 by M.D. Anderson Cancer Center
Study NCT01198028   Information provided by M.D. Anderson Cancer Center

First Received on September 8, 2010.   Last Updated on May 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Skin Cancer
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Squamous Cell
Skin Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Skin Diseases
Interventions listed in this trial
Erlotinib
Additional drug interventions recognized in this trial
Mitogens
More general drug interventions related to this trial
Enzyme Inhibitors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Sponsors listed in this trial
M.D. Anderson Cancer Center
OSI Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services